GECH
BTMD icon

Garnet Equity Capital Holdings’s Biote Corp BTMD Stock Holding History

Garnet Equity Capital Holdings’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-70,325
Closed -$435K – 35
2023
Q1 		$435K Buy
+70,325
New +$315K 0.22% 30

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Garnet Equity Capital Holdings's BTMD Position: Q2 2023 in Review

Garnet Equity Capital Holdings sold out of Biote Corp (BTMD) in Q2 2023, closing a stake of 70,325 shares — an estimated $435K sold.

Garnet Equity Capital Holdings first reported a position in BTMD in Q1 2023 and held it in 1 quarter. The position peaked at $435K in Q1 2023. 55 funds tracked by Wall St. Rank hold BTMD as of Q2 2023.

  • Garnet Equity Capital Holdings reported no remaining Biote Corp position as of Q2 2023 after selling out during the quarter.
  • Garnet Equity Capital Holdings sold 70,325 Biote Corp shares in Q2 2023, an estimated $435K.
  • Garnet Equity Capital Holdings first reported a position in Biote Corp in Q1 2023 and held it in 1 quarter.
  • Garnet Equity Capital Holdings's Biote Corp position peaked at $435K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Biote Corp as of Q2 2023.

Based on Garnet Equity Capital Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.